Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-RafV600E kinase

Mutations of the BRAF gene in human cancer

Helen Davies, Graham R. Bignell, Charles Cox et al. · Nature · 2002 · 10.6K citations · Full text

Somatic Variant, Braf Gene, Genetics +5

Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF

Paul Wan, Mathew J. Garnett, S. Mark Roe et al. · Cell · 2004 · 2.8K citations · Full text

Oncogenic Mutations, Signal Transduction, Signaling Pathway +9

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

James Tsai, John Tayu Lee, Weiru Wang et al. · Proceedings of the National Academy of Sciences · 2008 · 1.3K citations · Full text

Poor Survival Associated with the <i>BRAF</i> V600E Mutation in Microsatellite-Stable Colon Cancers

Wade S. Samowitz, Carol Sweeney, Jennifer S. Herrick et al. · Cancer Research · 2005 · 742 citations

The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membrane

Garcilaso Riesco‐Eizaguirre, Paula Gutierrez‐Martinez, Miguel Ángel García‐Cabezas et al. · Endocrine Related Cancer · 2006 · 366 citations · Full text